Abstract:The gut-brain axis plays an important role in mental health. The intestinal epithelial surface is colonized by billions of commensal and transitory bacteria, known as the Gut Microbiota (GM). However, potential pathogens continuously stimulate intestinal immunity when they find the place. The last two decades have witnessed several studies revealing intestinal bacteria as a key factor in the health-disease balance of the gut, as well as disease-emergent in other parts of the body. Various neurological processes, such as cognition, learning, and memory, could be affected by dysbiosis in GM. Additionally, the aging process and longevity are related to systemic inflammation caused by dysbiosis. Commensal GM affects brain development, behavior, and healthy aging suggesting that building changes in GM might be a potential therapeutic method. The innovation in GM dysbiosis is intervention by Fecal Microbiota Transplantation (FMT), which has been confirmed as a therapy for recurrent Clostridium difficile infections and is promising for other clinical disorders, such as Parkinson's disease, Multiple Sclerosis (MS), Alzheimer's disease, and depression. Additionally, FMT may be possible to promote healthy aging, and extend longevity. This review aims to connect dysbiosis, neurological disorders, and aging and the potential of FMT as a therapeutic strategy to treat these disorders, and to enhance the quality of life in the elderly.

Genetic and Environmental Factors in Alzheimer’s and Parkinson’s Diseases and Promising Therapeutic Intervention Via Fecal Microbiota Transplantation

Fecal microbiota transplantation: a novel strategy for treating Alzheimer's disease

The Gut Microbiome: an Important Role in Neurodegenerative Diseases and Their Therapeutic Advances.

Gut microbiota and Parkinson's disease: potential links and the role of fecal microbiota transplantation

Gut Microbiota Regulation and Their Implication in the Development of Neurodegenerative Disease

Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside

Gut Microbiota Mediates Neuroinflammation in Alzheimer’s Disease: Unraveling Key Factors and Mechanistic Insights

Fecal Microbiota Transplantation: A New Therapeutic Attempt from the Gut to the Brain

Gut Microbiota and Parkinson’s Disease: Implications for Faecal Microbiota Transplantation Therapy

Gut Microbiota and Parkinson's Disease: Implications for Faecal Microbiota Transplantation Therapy

Therapeutic Prospect of New Probiotics in Neurodegenerative Diseases

[Advances in the application of fecal microbiota transplantation for the treatment of nervous system diseases]

The Relationship Between the Gut Microbiome and Neurodegenerative Diseases

Fecal Microbiota Transplantation Alleviated Alzheimer’s Disease-Like Pathogenesis in APP/PS1 Transgenic Mice

Effect of fecal microbiota transplantation on patients with sporadic amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled trial

Gut Microbiome-Targeted Therapies for Alzheimer's Disease

Gut-brain axis and neurodegeneration: mechanisms and therapeutic potentials

Dysbiosis and fecal microbiota transplant: Contemplating progress in health, neurodegeneration and longevity

Gut Microbiota And Alzheimer'S Disease: Pathophysiology And Therapeutic Perspectives

Research Progress of Microbiota-Gut-Brain Axis in Parkinson's Disease

Gut microbiota: the indispensable player in neurodegenerative diseases